Alkem Laboratories Limited (NSE:ALKEM)
5,482.50
+80.00 (1.48%)
Feb 16, 2026, 11:50 AM IST
Alkem Laboratories Revenue
Alkem Laboratories had revenue of 37.37B INR in the quarter ending December 31, 2025, with 10.74% growth. This brings the company's revenue in the last twelve months to 142.53B, up 11.73% year-over-year. In the fiscal year ending March 31, 2025, Alkem Laboratories had annual revenue of 129.65B with 2.34% growth.
Revenue (ttm)
142.53B
Revenue Growth
+11.73%
P/S Ratio
4.53
Revenue / Employee
7.59M
Employees
18,785
Market Cap
645.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 129.65B | 2.97B | 2.34% |
| Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
| Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
| Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
| Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Mankind Pharma | 139.14B |
| Divi's Laboratories | 103.14B |
| Ipca Laboratories | 93.59B |
| Emcure Pharmaceuticals | 88.50B |
Alkem Laboratories News
- 2 days ago - Alkem Laboratories Ltd (BOM:539523) Q3 2026 Earnings Call Highlights: Strong International ... - GuruFocus
- 2 days ago - Q3 2026 Alkem Laboratories Ltd Earnings Call Transcript - GuruFocus
- 2 days ago - Alkem Laboratories board declares interim dividend of Rs 43 per share for FY26 - Business Upturn
- 2 days ago - Alkem Laboratories Q3 Results: Revenue jumps 10.7% YoY to Rs 3,736.82 crore, net profit up 1.9% - Business Upturn
- 3 days ago - Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Reports Q3 2026 Result - GuruFocus
- 24 days ago - Alkem Laboratories receives GST demand order of Rs 2.35 crore; company plans appeal - Business Upturn
- 4 weeks ago - Stocks to buy: What's the outlook for Nifty for the week starting January 12, 2026? Check list of top stock recommendations - The Times of India
- 2 months ago - Alkem Laboratories’ Daman facility clears Malta GMP inspection with no critical observations - Business Upturn